Hazlett, Burt & Watson’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-124
Closed -$4K 724
2024
Q1
$4K Sell
124
-61
-33% -$1.69K ﹤0.01% 608
2023
Q4
$6K Hold
185
﹤0.01% 546
2023
Q3
$7K Buy
185
+61
+49% +$2.33K 0.01% 535
2023
Q2
$5K Buy
+124
New +$4.86K ﹤0.01% 562

Other funds holding RTO

Hazlett, Burt & Watson's RTO Position: Q2 2024 in Review

Hazlett, Burt & Watson sold out of Rentokil (RTO) in Q2 2024, closing a stake of 124 shares — an estimated $4K sold.

Hazlett, Burt & Watson first reported a position in RTO in Q2 2023 and held it in 4 quarters. The position peaked at $7K in Q3 2023. 232 funds tracked by Wall St. Rank hold RTO as of Q2 2024.

  • Hazlett, Burt & Watson reported no remaining Rentokil position as of Q2 2024 after selling out during the quarter.
  • Hazlett, Burt & Watson sold 124 Rentokil shares in Q2 2024, an estimated $4K.
  • Hazlett, Burt & Watson first reported a position in Rentokil in Q2 2023 and held it in 4 quarters.
  • Hazlett, Burt & Watson's Rentokil position peaked at $7K in Q3 2023.
  • 232 funds tracked by Wall St. Rank held Rentokil as of Q2 2024.

Based on Hazlett, Burt & Watson's 13F filing for Q2 2024, filed 7 Aug 2024.